Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancer (Q83215414)
Jump to navigation
Jump to search
scientific article published on 26 April 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancer |
scientific article published on 26 April 2006 |
Statements
Reduced incidence of severe palmar-plantar erythrodysesthesia and mucositis in a prospective multicenter phase II trial with pegylated liposomal doxorubicin at 40 mg/m2 every 4 weeks in previously treated patients with metastatic breast cancer (English)
Salah-Eddin Al-Batran
Hans-Gerd Meerpohl
Akin Atmaca
Ulrich Kleeberg
Nadia Harbeck
Werner Lerbs
Detlef Hecker
Jalid Sehouli
Alexander Knuth